[1] |
ORMSBEE M J, PRADO C M, ILICH J Z,et al. Osteosarcopenic obesity:the role of bone,muscle,and fat on health[J]. J Cachexia Sarcopenia Muscle, 2014, 5(3):183-192. DOI: 10.1007/s13539-014-0146-x.
|
[2] |
ILICH J Z, KELLY O J, INGLIS J E. Osteosarcopenic obesity syndrome:what is it and how can it be identified and diagnosed[J]. Curr Gerontol Geriatr Res, 2016, 2016:7325973. DOI: 10.1155/2016/7325973.
|
[3] |
SCOTT D, CHANDRASEKARA D, LASLETT L L,et al. Associations of sarcopenicobesity and dynapenic obesity with bone mineral density and incident fractures over 5-10 years incommunity-dwelling older adults[J]. Calcif Tissue Int, 2016, 99(1):30-42. DOI: 10.1007/s00223-016-0123-9.
|
[4] |
CRUZ-JENTOFT A J, BAEYENS J P, BAUER J M,et al. Sarcopenia:European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People[J]. Age Ageing, 2010, 39(4):412-423. DOI: 10.1093/ageing/afq034.
|
[5] |
CHEN L K, WOO J, ASSANTACHAI P,et al. Asian Working Group for Sarcopenia:2019 consensus update on sarcopenia diagnosisand treatment[J]. J Am Med Dir Assoc, 2020, 21(3):300-307,e2. DOI: 10.1016/j.jamda.2019.12.012.
|
[6] |
SCOTT D, SEIBEL M, CUMMING R,et al. Sarcopenic obesity and its temporal associations with changes in bone mineral density,incident falls and fractures in older men:the concord health and ageing in men project[J]. J Bone Miner Res, 2016, 32(3):575-583. DOI: 10.1002/jbmr.3016.
|
[7] |
DE LAET C, KANIS J A, ODEN A,et al. Body mass index as a predictor of fracture risk:a meta-analysis[J]. Osteoporos Int, 2005, 16(11):1330-1338. DOI: 10.1007/s00198-005-1863-y.
|
[8] |
COMPSTON J E, WATTS N B, CHAPURLAT R,et al. Obesity is not protective against fracture in postmenopausal women:GLOW[J]. Am J Med, 2011, 124(11):1043-1050. DOI: 10.1016/j.amjmed.2011.06.013.
|
[9] |
MA Y, ZHANG W, HAN P,et al. Osteosarcopenic obesity associated with poor physical performance in the elderly Chinese community[J]. Clin Interv Aging, 2020, 15:1343-1352. DOI: 10.2147/CIA.S257739.
|
[10] |
BAE Y J. Fruit intake and osteosarcopenic obesity in Korean postmenopausal women aged 50-64 years[J]. Maturitas, 2020, 134:41-46. DOI: 10.1016/j.maturitas.2020.02.003.
|
[11] |
SALECH F, MARQUEZ C, LERA L,et al. Osteosarcopenia predicts falls,fractures,and mortality in Chilean community-dwelling older adults[J]. J Am Med Dir Assoc, 2021, 22(4):853-858. DOI: 10.1016/j.jamda.2020.07.032.
|
[12] |
The WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis[EB/OL]. [2021-11-15].
|
[13] |
CHOI B, STEISS D, GARCIA-RIVAS J,et al. Comparison of body mass index with waist circumference and skinfold-based percent body fat in firefighters:adiposity classification and associations with cardiovascular disease risk factors[J]. Int Arch Occup Environ Health, 2016, 89(3):435-448. DOI: 10.1007/s00420-015-1082-6.
|
[14] |
孙振球. 医学统计学[M]. 3版. 北京:人民卫生出版社,2010.
|
[15] |
|
[16] |
OLIVEROS E, SOMERS V K, SOCHOR O,et al. The concept of normal weight obesity[J]. Prog Cardiovasc Dis, 2014, 56(4):426-433. DOI: 10.1016/j.pcad.2013.10.003.
|
[17] |
HUNG S P, CHEN C Y, GUO F R,et al. Combine body mass index and body fat percentage measures to improve the accuracy of obesity screening in young adults[J]. Obes Res Clin Pract, 2017, 11(1):11-18. DOI: 10.1016/j.orcp.2016.02.005.
|
[18] |
BEN-HUR A, GUYON I. Detecting stable clusters using principal component analysis[J]. Methods Mol Biol, 2003, 224:159-182. DOI: 10.1385/1-59259-364-X:159.
|
[19] |
BURGEL P R, ROCHE N, PAILLASSEUR J L,et al. Clinical COPD phenotypes identified by cluster analysis:validation with mortality[J]. Eur Respir J, 2012, 40(2):495-496. DOI: 10.1183/09031936.00228511.
|
[20] |
WOOLSTON A, TU Y K, BAXTER P D,et al. A comparison of different approaches to unravel the latent structure within metabolic syndrome[J]. PLoS One, 2012, 7(4):e34410. DOI: 10.1371/journal.pone.0034410.
|
[21] |
ABBASI M, NEISHABOURY M, KOOHPAYEHZADEH J,et al. National prevalence of self-reported coronary heart disease and chronic stable-angina pectoris:factor analysis of the underlying cardiometabolic risk factors in the SuRFNCD-2011[J]. Glob Heart, 2018, 13(2):73-82,e1. DOI: 10.1016/j.gheart.2018.01.001.
|
[22] |
KOLIAKI C, LIATIS S, DALAMAGA M,et al. Sarcopenicobesity:epidemiologicevidence,pathophysiology,and therapeutic perspectives[J]. Curr Obes Rep, 2019, 8(4):458-471. DOI: 10.1007/s13679-019-00359-9.
|
[23] |
KELLY O J, GILMAN J C, BOSCHIERO D,et al. Osteosarcopenic obesity:current knowledge,revised identification criteria and treatment principle[J]. Nutrients, 2019, 30,11(4):747. DOI: 10.3390/nu11040747.
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
NISHINO T, ENDO S, MIYANO H,et al. Reference serum creatinine levels according to sex,age,and height in children with down syndrome[J]. Eur J Pediatr, 2021, 180(9):2977-2983. DOI: 10.1007/s00431-021-04078-z.
|
[29] |
KURAHASHI H, WATANABE M, SUGIMOTO M,et al. Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder[J]. Endocr J, 2013, 60(12):1321-1327. DOI: 10.1507/endocrj.ej13-0203.
|